home
about us
related links
our team
leadership
staff
affiliates
our services
our clients
our experience
presentations
aptuit consulting overview
accelerating availability of new drugs for patients with serious disease
pharmaceutical salts and obviousness
implementing a preclinical program for biotechnology derived proteins
investigational new drug applications; same information different formats (us/eu)
application of 'omics technologies and pathway biology in pharmaceutical development
white papers
publications
animations
careers
offices
news
contact us
Strategic Planning
Manufacturing
PreClinical
Regulatory
Clinical
GxP Quality/Compliance
Patent Support
Counterfeit Analysis
Asset Evaluation
White Papers
Kerns W, Outsourcing: What is the path forward? The BioPharm International Guide, April 2007.
Click here to view
Patmore L, High Stakes – Managing QT Risk, European Pharmaceutical Contractor, Winter 2006, pp 80-85, 2006
Patmore L and Gaskin P, Outsourcing Strategies - from David to Goliath, European Pharmaceutical Contractor, Autumn 2007, pp 8-12, 2007
Click here to view
Len Chyall, Aeri Park et. al, New Solid State Chemistry Technologies to Bring Better Drugs to Market: Knowledge-based Decision Making, Informa Healthcare, 2007
Paul Fagan, Fixing Form and Formulation for Phase 1, European Pharmaceutical Contractor, Winter 2007